期刊文献+

原发性输尿管肿瘤行保留肾脏治疗的临床分析 被引量:1

Clinical study on kidney-sparing surgery in treating the primary transitional cell carcinoma of ureter
原文传递
导出
摘要 目的:探讨原发性输尿管肿瘤行保留肾脏治疗的疗效和安全性。方法:回顾性分析了29例输尿管癌患者保肾治疗的临床资料,输尿管镜下肿物切除术3例,腹腔镜下段输尿管肿瘤切除直接膀胱再吻合5例,中段肿瘤切除行膀胱翻瓣术3例,开放手术行肿瘤切除后输尿管膀胱直接再吻合10例,膀胱翻瓣术5例,输尿管端端吻合3例。术后均行膀胱灌注化疗,3例行全身化疗。结果:病理均为移行细胞癌。分级:低度恶性倾向乳头状瘤4例,低分级乳头状尿路上皮癌13例,高分级12例。临床分期:T15例,T218例,T36例。术后膀胱癌发生率10.3%(3/29),同侧上尿路癌复发3.4%(1/29),尿漏2例,轻度肾积水5例,3例术后死于心肺疾病。在低级别肿瘤,膀胱癌复发率5.9%(1/17),在T1期5例中未见复发,T2期18例中膀胱癌和同侧上尿路癌复发率11.1%(2/18),T3期6例中膀胱癌复发率33.3%(2/6)。结论:保留肾脏术式可以选择性用于单发、低级别或术前影像低分期的中下段输尿管肿瘤,输尿管镜和腹腔镜手术都需加强密切随访。 Objective:To evaluate the clinical safety and efficacy of kidney-sparing surgery in treating the primary transitional cell carcinoma of ureter.Method:The data of 29 cases who underwent kidney-sparing surgery for treatment of the carcinoma of ureter were analyzed retrospectively.There were three cases undergoing endoscopic ablation,eight cases undergoing laparoscopy(five direct ureterocystoneostomies,three reimplantations on Boari flap bladder),18 cases undergoing open surgeries(ten direct ureterocystoneostomies,five reimplantations on Boari flap bladder,and three end-to-end anastomoses).All the patients received regular intravesical instillation,and three of them also received intravenous chemotherapy.Result:All the pathology were transitional cell carcinoma,including four papillary urothelial neoplasms of low malignancy,13low-grade papillary urothelial carcinoma,and 12high-grade papillary urothelial carcinoma.Clinical Stage was classified T15,T218 and T36.The recurrence in bladder and ipsilateral upper ureter was 10.3% and 3.4%,respectively.Two cases suffered from urine leak,and five cases had mild hydronephrosis.Moreover,three cases died of heart and lung diseases.The recurrence in bladder was 5.9%in low-grade tumors,and the recurrence in bladder and ipsilateral ureter was 11.1%in T2 tumors,33.3%in T3 tumors.Conclusion:Kidney-sparing surgery is a feasible treatment option for the selected patients with unifocal middle or distal ureteric carcinoma at low grade or without invasive aspect on CT.Laparoscopic ureterocystoneostomy or endoscopic management has more minimally invasive advantages in the treatment.However,a close follow-up is recommended.
出处 《临床泌尿外科杂志》 2015年第10期920-922,共3页 Journal of Clinical Urology
关键词 输尿管癌 保留肾脏手术 ureter carcinoma kidney-sparing surgery
  • 相关文献

参考文献14

  • 1Colin P, Ouzzane A, Pignot G, et al. Comparison oI ontological outcomes after segmental uretereetomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results {rom a large French multicentre study[J]. BJLT Int, 2012, 110(8): 1134- 1141.
  • 2张继伟,王海涛,王建军,白焱,夏溟.保留肾脏术式治疗原发性输尿管癌临床分析[J].首都医科大学学报,2012,33(5):586-588. 被引量:7
  • 3Roupr6t M, Babjuk M, Comp6rat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update[J]. Eur Urol, 2013, 63(6): 1059-1071.
  • 4Montie J E, Clark P E, Eisenberger M A, et al. Blad- der Cancer[J]. J Natl Compr Canc Netw, 2009, 7(1): 8-39.
  • 5Rai B P, Shelley M, Coles B, et al. Surgical manage- ment for upper urinary tract transitional cell carcinoma (UUT-TCC) : a systematic review[J]. BJU Int, 2012, 110(10) : 1426-1435.
  • 6Ho K L, Chow G K. Ureteroscopic resection of upper- tract transitional cell carcinoma[J]. J Endourol, 2005, 19(7) : 841-848.
  • 7Box G N, Lehman D S, Landman J, et al. Minimally invasive management of upper tract malignancies: renal cell and transitional cell carcinoma[J]. Urol Clin North Am, 2008, 35(3): 365-383.
  • 8王小波,李健,冯起庆,李昭夷.早期输尿管癌保肾手术的临床疗效分析(附15例报告)[J].临床泌尿外科杂志,2013,28(7):520-521. 被引量:6
  • 9Cutress M L, Stewart G D, Wells Cole S, et al. Long- term endoscopic management of upper tract urothelial carcinoma= 20-year single-center experienee [J]. BJU Int, 2012, 110(11)= 1608-1617.
  • 10Park B H, Jeon S S. Endoscopic management of upper urinary tract urothelial carcinoma [J] Korean J Urol, 2013, 54 (7): 426 432.

二级参考文献37

  • 1张争,潘柏年.原发性输尿管癌影响预后因素分析[J].中华泌尿外科杂志,2004,25(12):838-840. 被引量:19
  • 2潘柏年,张争,刘玉立,郭应禄.174例原发性输尿管癌的临床分析[J].中华外科杂志,2004,42(23):1447-1449. 被引量:59
  • 3张玉石,李汉忠,张锐强,纪志刚.伴有肾功能不全的上尿路移行细胞癌的诊断和治疗(附42例报告)[J].临床泌尿外科杂志,2007,22(9):673-675. 被引量:2
  • 4Ni(t)(a)G,Georgescu D,Mul escu R,et al.Prognostic factors in laser treatment of upper urinary tract urothelial tumours.J Med Life.2012 Feb 22;5(1):33~8.
  • 5Xu AD,Ng CS,Kamat A,Grossman HB,Dinney C,Sandler CM.Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms.AJR Am J Roentgenol.2010 Oct;195(4):959~65.
  • 6Messer J,Lin YK,Raman JD.The role of lymphadenectomy for upper tract urothelial carcinoma.Nat Rev Urol.2011 May 24;8(7):394~401.
  • 7Munoz JJ,Ellison LM.Upper tract urothelial neoplasms:incidence and survival during the last 2 decades[J].J Urol,2000; 164(5):1523~1525.
  • 8Oosterlinck W,Solsona E,Vander Meijden AP,et al EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma Eur Urol,2004;46(2):147~154.
  • 9O'Brien T,Ray E,Singh R,et al.Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma:a prospective,multicentre,randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).Eur Urol.2011Oct;60(4):703~10.
  • 10Ouzzane A,Ghoneim TP,Udo K,et al.Small cell carcinoma of the upper urinary tract (UUT-SCC):report of a rare entity and systematic review of the literature.Cancer Treat Rev.2011 Aug;37(5):366~72.

共引文献8

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部